Ginkgo Bioworks Holdings Inc (DNA) reports significant cash burn reduction and revenue growth in Cell Engineering, while navigating declines in Biosecurity revenue and market uncertainties.
Couchbase Inc (BASE) reports robust Q4 results with significant ARR growth, positive free cash flow, and strategic advancements in Capella adoption.